SIP
LSTA icon

Stoneridge Investment Partners’s Lisata Therapeutics LSTA Stock Holding History

Stoneridge Investment Partners’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-543
Closed -$307K – 285
2014
Q4 		$307K Buy
+543
New +$370K 0.04% 217

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Stoneridge Investment Partners's LSTA Position: Q1 2015 in Review

Stoneridge Investment Partners sold out of Lisata Therapeutics (LSTA) in Q1 2015, closing a stake of 543 shares — an estimated $307K sold.

Stoneridge Investment Partners first reported a position in LSTA in Q4 2014 and held it in 1 quarter. The position peaked at $307K in Q4 2014. 52 funds tracked by Wall St. Rank hold LSTA as of Q1 2015.

  • Stoneridge Investment Partners reported no remaining Lisata Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Stoneridge Investment Partners sold 543 Lisata Therapeutics shares in Q1 2015, an estimated $307K.
  • Stoneridge Investment Partners first reported a position in Lisata Therapeutics in Q4 2014 and held it in 1 quarter.
  • Stoneridge Investment Partners's Lisata Therapeutics position peaked at $307K in Q4 2014.
  • 52 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2015.

Based on Stoneridge Investment Partners's 13F filing for Q1 2015, filed 23 Apr 2015.